Aymeric Sallin - Jan 3, 2022 Form 4 Insider Report for SELECTA BIOSCIENCES INC (SELB)

Role
Director
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Aymeric Sallin
Stock symbol
SELB
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
4
Date filed
1/5/2022, 03:35 PM
Next filing
Jan 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SELB Stock Option (Right to Buy) Award $0 +40K $0.00 40K Jan 3, 2022 Common Stock 40K $3.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of Common Stock underlying this award will vest in full on January 3, 2023.